Including results for ecarx investor relations
Search only for ocrx investor relations
The Investor Relations website contains information about ECARX Holdings, Inc.'s business for stockholders, potential investors, and financial analysts.
Missing: ocrx | Show results with:ocrx
Nov 9, 2017 · The information relating to the number of shares of Ocera common stock is based on information provided by Ocera as of October 30, 2017. **. The ...
The Investor Relations website contains information about Nurix Therapeutics, Inc. 's business for stockholders, potential investors, and financial analysts.
Missing: ocrx | Show results with:ocrx
Results, Reports and Presentations | ECARX Holdings, Inc.
ir.ecarxgroup.com › news-events › result...
Results, Reports and Presentations ; May 09, 2023, ECARX Investor Day 2023. PDF Version 126.8 KB. Investor Day Presentation 13.2 MB ; April 24, 2023, Q4/FY 2022 ...
Missing: ocrx | Show results with:ocrx
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports ( ...
A high-level overview of Ocera Therapeutics, Inc. (OCRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and ...
Missing: relations | Show results with:relations
Susan Sharpe. PRESENT. Investor Relations. Board Members. Name/Company. Dr Eckard Weber. Dr Wendell D Wierenga. Santarus Inc. Dr Willard H Dere. View More. View ...
People also ask
What does Ecarx do?
What is a good investor relations?
Ocera Therapeutics Inc - OCRX data available via the Intrinio API ... Investor Relations. Educational Communities ... Ocera Therapeutics Inc (NASDAQ:OCRX), a ...
Ocera Therapeutics Annual Report | NASDAQ:OCRX Financials
m.uk.investing.com › equities › ocera-th...
View real-time Ocera Therapeutics Inc (OCRX) share prices and assess historical data, charts, technical analysis, performance reports and NASDAQ OCRX share ...
Ocera Therapeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%. Investors interested in the biomedical industry may also consider stocks ...